| Identification | Back Directory | [Name]
Turosteride | [CAS]
137099-09-3 | [Synonyms]
Turosteride
1H-Indeno[5,4-f]quinoline-7-carboxamide, hexadecahydro-1,4a,6a-trimethyl-N-(1-methylethyl)-N-[[(1-methylethyl)amino]carbonyl]-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)- | [Molecular Formula]
C27H45N3O3 | [MOL File]
137099-09-3.mol | [Molecular Weight]
459.66 |
| Hazard Information | Back Directory | [Uses]
Turosteride is a selective 5 alpha-reductase inhibitor, with IC50 values of 55 and 53 nM for human and rat prostatic 5 alpha-reductases, respectively. Turosteride can reduce the prostate and seminal vesicle weights[1]. | [References]
[1] Di Salle E, et al. Endocrine properties of the testosterone 5 alpha-reductase inhibitor turosteride (FCE 26073). J Steroid Biochem Mol Biol. 1994 Feb;48(2-3):241-8. DOI:10.1016/0960-0760(94)90151-1 |
|
| Company Name: |
LGM Pharma
|
| Tel: |
1-(800)-881-8210 |
| Website: |
www.lgmpharma.com |
|